nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—RET—autonomic nervous system—conduct disorder	0.0276	0.0538	CbGeAlD
Sunitinib—DYRK2—brain—conduct disorder	0.0108	0.0211	CbGeAlD
Sunitinib—HUNK—brain—conduct disorder	0.00965	0.0188	CbGeAlD
Sunitinib—GRK4—brain—conduct disorder	0.00882	0.0172	CbGeAlD
Sunitinib—TLK2—brain—conduct disorder	0.0082	0.016	CbGeAlD
Sunitinib—MYLK4—brain—conduct disorder	0.0082	0.016	CbGeAlD
Sunitinib—MYLK3—brain—conduct disorder	0.00794	0.0155	CbGeAlD
Sunitinib—GRK1—brain—conduct disorder	0.00697	0.0136	CbGeAlD
Sunitinib—NIM1K—brain—conduct disorder	0.00697	0.0136	CbGeAlD
Sunitinib—ERN1—brain—conduct disorder	0.00669	0.013	CbGeAlD
Sunitinib—PRKAA2—brain—conduct disorder	0.00669	0.013	CbGeAlD
Sunitinib—PIP4K2B—brain—conduct disorder	0.00669	0.013	CbGeAlD
Sunitinib—MAST1—brain—conduct disorder	0.00656	0.0128	CbGeAlD
Sunitinib—STK17B—brain—conduct disorder	0.00644	0.0125	CbGeAlD
Sunitinib—DCLK3—brain—conduct disorder	0.00622	0.0121	CbGeAlD
Sunitinib—STK17A—brain—conduct disorder	0.00593	0.0115	CbGeAlD
Sunitinib—CDK14—brain—conduct disorder	0.00584	0.0114	CbGeAlD
Sunitinib—CDK16—brain—conduct disorder	0.00576	0.0112	CbGeAlD
Sunitinib—LATS2—brain—conduct disorder	0.00576	0.0112	CbGeAlD
Sunitinib—PAK3—brain—conduct disorder	0.00576	0.0112	CbGeAlD
Sunitinib—STK33—brain—conduct disorder	0.00569	0.0111	CbGeAlD
Sunitinib—RPS6KA5—brain—conduct disorder	0.00569	0.0111	CbGeAlD
Sunitinib—CLK4—brain—conduct disorder	0.00547	0.0107	CbGeAlD
Sunitinib—SBK1—brain—conduct disorder	0.00541	0.0105	CbGeAlD
Sunitinib—HIPK4—brain—conduct disorder	0.00535	0.0104	CbGeAlD
Sunitinib—PHKG1—brain—conduct disorder	0.00529	0.0103	CbGeAlD
Sunitinib—DAPK1—brain—conduct disorder	0.00529	0.0103	CbGeAlD
Sunitinib—STK11—brain—conduct disorder	0.00512	0.00997	CbGeAlD
Sunitinib—BRD4—brain—conduct disorder	0.00512	0.00997	CbGeAlD
Sunitinib—RIOK1—brain—conduct disorder	0.00507	0.00987	CbGeAlD
Sunitinib—RPS6KA1—brain—conduct disorder	0.00507	0.00987	CbGeAlD
Sunitinib—MARK2—brain—conduct disorder	0.00497	0.00968	CbGeAlD
Sunitinib—TNIK—brain—conduct disorder	0.00497	0.00968	CbGeAlD
Sunitinib—SGK3—brain—conduct disorder	0.00492	0.00959	CbGeAlD
Sunitinib—ICK—brain—conduct disorder	0.00488	0.0095	CbGeAlD
Sunitinib—CHEK2—brain—conduct disorder	0.00471	0.00917	CbGeAlD
Sunitinib—NUAK1—brain—conduct disorder	0.00471	0.00917	CbGeAlD
Sunitinib—INSR—brain—conduct disorder	0.00467	0.0091	CbGeAlD
Sunitinib—OXSR1—brain—conduct disorder	0.00467	0.0091	CbGeAlD
Sunitinib—SNRK—brain—conduct disorder	0.00467	0.0091	CbGeAlD
Sunitinib—STK38—brain—conduct disorder	0.0046	0.00895	CbGeAlD
Sunitinib—RPS6KA2—brain—conduct disorder	0.0046	0.00895	CbGeAlD
Sunitinib—AURKC—brain—conduct disorder	0.00456	0.00888	CbGeAlD
Sunitinib—PKN1—brain—conduct disorder	0.00453	0.00882	CbGeAlD
Sunitinib—CSNK1G2—brain—conduct disorder	0.00453	0.00882	CbGeAlD
Sunitinib—PRPF4—brain—conduct disorder	0.00446	0.00869	CbGeAlD
Sunitinib—PRPF4B—brain—conduct disorder	0.0044	0.00856	CbGeAlD
Sunitinib—STK39—brain—conduct disorder	0.00434	0.00845	CbGeAlD
Sunitinib—CSNK2A1—brain—conduct disorder	0.00428	0.00834	CbGeAlD
Sunitinib—MYLK—brain—conduct disorder	0.00423	0.00823	CbGeAlD
Sunitinib—PLK4—brain—conduct disorder	0.00417	0.00813	CbGeAlD
Sunitinib—STK4—brain—conduct disorder	0.00415	0.00808	CbGeAlD
Sunitinib—PHKG2—brain—conduct disorder	0.00407	0.00793	CbGeAlD
Sunitinib—STK24—brain—conduct disorder	0.00405	0.00789	CbGeAlD
Sunitinib—DAPK2—brain—conduct disorder	0.00401	0.0078	CbGeAlD
Sunitinib—STK16—brain—conduct disorder	0.00394	0.00767	CbGeAlD
Sunitinib—HIPK2—brain—conduct disorder	0.00392	0.00763	CbGeAlD
Sunitinib—HIPK3—brain—conduct disorder	0.00392	0.00763	CbGeAlD
Sunitinib—ALK—brain—conduct disorder	0.00392	0.00763	CbGeAlD
Sunitinib—TYRO3—brain—conduct disorder	0.00392	0.00763	CbGeAlD
Sunitinib—TNK1—brain—conduct disorder	0.00388	0.00755	CbGeAlD
Sunitinib—RIOK2—brain—conduct disorder	0.00388	0.00755	CbGeAlD
Sunitinib—MAP4K1—brain—conduct disorder	0.00384	0.00748	CbGeAlD
Sunitinib—MAP3K19—brain—conduct disorder	0.00384	0.00748	CbGeAlD
Sunitinib—DAPK3—brain—conduct disorder	0.00377	0.00733	CbGeAlD
Sunitinib—CLK2—brain—conduct disorder	0.00373	0.00727	CbGeAlD
Sunitinib—MAP4K2—brain—conduct disorder	0.00371	0.00723	CbGeAlD
Sunitinib—STK3—brain—conduct disorder	0.00366	0.00713	CbGeAlD
Sunitinib—ROCK1—brain—conduct disorder	0.00362	0.00704	CbGeAlD
Sunitinib—DYRK1A—brain—conduct disorder	0.00353	0.00687	CbGeAlD
Sunitinib—MERTK—brain—conduct disorder	0.00344	0.00671	CbGeAlD
Sunitinib—MAP4K4—brain—conduct disorder	0.00338	0.00658	CbGeAlD
Sunitinib—NUAK2—brain—conduct disorder	0.00336	0.00654	CbGeAlD
Sunitinib—MAP3K12—brain—conduct disorder	0.00333	0.00649	CbGeAlD
Sunitinib—RPS6KA3—brain—conduct disorder	0.00329	0.0064	CbGeAlD
Sunitinib—MAP2K1—brain—conduct disorder	0.00327	0.00636	CbGeAlD
Sunitinib—CSNK1A1—brain—conduct disorder	0.00322	0.00628	CbGeAlD
Sunitinib—CLK1—brain—conduct disorder	0.0032	0.00624	CbGeAlD
Sunitinib—CAMK2G—brain—conduct disorder	0.00314	0.00612	CbGeAlD
Sunitinib—BMP2K—brain—conduct disorder	0.00314	0.00612	CbGeAlD
Sunitinib—LRRK2—brain—conduct disorder	0.00312	0.00607	CbGeAlD
Sunitinib—PRKAA1—brain—conduct disorder	0.00307	0.00598	CbGeAlD
Sunitinib—PTK2B—brain—conduct disorder	0.00304	0.00591	CbGeAlD
Sunitinib—FLT4—brain—conduct disorder	0.00303	0.0059	CbGeAlD
Sunitinib—CSNK1E—brain—conduct disorder	0.00299	0.00582	CbGeAlD
Sunitinib—FGFR1—brain—conduct disorder	0.00299	0.00582	CbGeAlD
Sunitinib—IRAK4—brain—conduct disorder	0.00294	0.00573	CbGeAlD
Sunitinib—ULK3—brain—conduct disorder	0.00287	0.0056	CbGeAlD
Sunitinib—MAP2K2—brain—conduct disorder	0.00287	0.0056	CbGeAlD
Sunitinib—MAP3K2—brain—conduct disorder	0.00285	0.00556	CbGeAlD
Sunitinib—MAP3K7—brain—conduct disorder	0.00283	0.00551	CbGeAlD
Sunitinib—TBK1—brain—conduct disorder	0.0028	0.00544	CbGeAlD
Sunitinib—TYK2—brain—conduct disorder	0.00278	0.00541	CbGeAlD
Sunitinib—IRAK1—brain—conduct disorder	0.00274	0.00534	CbGeAlD
Sunitinib—RPS6KB1—brain—conduct disorder	0.00269	0.00524	CbGeAlD
Sunitinib—FGR—brain—conduct disorder	0.00267	0.0052	CbGeAlD
Sunitinib—RET—brain—conduct disorder	0.00267	0.0052	CbGeAlD
Sunitinib—AXL—brain—conduct disorder	0.00266	0.00518	CbGeAlD
Sunitinib—SLK—brain—conduct disorder	0.00256	0.00499	CbGeAlD
Sunitinib—FGFR2—brain—conduct disorder	0.00254	0.00495	CbGeAlD
Sunitinib—JAK2—brain—conduct disorder	0.00253	0.00492	CbGeAlD
Sunitinib—FYN—brain—conduct disorder	0.00249	0.00485	CbGeAlD
Sunitinib—MAP3K3—brain—conduct disorder	0.00243	0.00474	CbGeAlD
Sunitinib—MAP4K5—brain—conduct disorder	0.00243	0.00474	CbGeAlD
Sunitinib—FLT1—brain—conduct disorder	0.00235	0.00458	CbGeAlD
Sunitinib—EPHB6—brain—conduct disorder	0.00233	0.00453	CbGeAlD
Sunitinib—YES1—brain—conduct disorder	0.00225	0.00438	CbGeAlD
Sunitinib—STK10—brain—conduct disorder	0.00223	0.00434	CbGeAlD
Sunitinib—TAOK3—brain—conduct disorder	0.00222	0.00432	CbGeAlD
Sunitinib—PDGFRA—brain—conduct disorder	0.00221	0.0043	CbGeAlD
Sunitinib—KDR—brain—conduct disorder	0.00199	0.00387	CbGeAlD
Sunitinib—MAP2K5—brain—conduct disorder	0.00199	0.00387	CbGeAlD
Sunitinib—CSF1R—brain—conduct disorder	0.00194	0.00378	CbGeAlD
Sunitinib—KIT—brain—conduct disorder	0.00176	0.00343	CbGeAlD
Sunitinib—PDGFRB—brain—conduct disorder	0.00172	0.00335	CbGeAlD
Sunitinib—ABCC4—brain—conduct disorder	0.00137	0.00267	CbGeAlD
Sunitinib—KCNH2—brain—conduct disorder	0.00109	0.00212	CbGeAlD
Sunitinib—ABCG2—brain—conduct disorder	0.000968	0.00189	CbGeAlD
Sunitinib—ABCB1—brain—conduct disorder	0.000477	0.00093	CbGeAlD
Sunitinib—RPS6KB1—Signaling Pathways—WASF1—conduct disorder	0.000191	0.000393	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—WASF1—conduct disorder	0.000191	0.000393	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—WASF1—conduct disorder	0.000191	0.000392	CbGpPWpGaD
Sunitinib—CHEK2—Cell Cycle—EP300—conduct disorder	0.00019	0.00039	CbGpPWpGaD
Sunitinib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000188	0.000387	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—HTR2A—conduct disorder	0.000187	0.000385	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—WASF1—conduct disorder	0.000186	0.000383	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CGA—conduct disorder	0.000186	0.000382	CbGpPWpGaD
Sunitinib—FYN—Immune System—WASF1—conduct disorder	0.000184	0.000378	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CGA—conduct disorder	0.000184	0.000377	CbGpPWpGaD
Sunitinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000183	0.000377	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—WASF1—conduct disorder	0.000183	0.000376	CbGpPWpGaD
Sunitinib—CSNK1E—Cell Cycle, Mitotic—EP300—conduct disorder	0.000182	0.000374	CbGpPWpGaD
Sunitinib—RPS6KA1—Innate Immune System—EP300—conduct disorder	0.000181	0.000372	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CGA—conduct disorder	0.00018	0.000371	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CGA—conduct disorder	0.00018	0.000371	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—HTR2A—conduct disorder	0.00018	0.00037	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—DRD4—conduct disorder	0.000176	0.000362	CbGpPWpGaD
Sunitinib—JAK2—Immune System—WASF1—conduct disorder	0.000175	0.000359	CbGpPWpGaD
Sunitinib—PHKG1—Disease—EP300—conduct disorder	0.000174	0.000357	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—HTR2A—conduct disorder	0.000174	0.000357	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—HTR2A—conduct disorder	0.000171	0.000352	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—HTR2A—conduct disorder	0.000171	0.000352	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CGA—conduct disorder	0.000171	0.000352	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CGA—conduct disorder	0.000171	0.000351	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—DRD4—conduct disorder	0.000169	0.000347	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—HTR2A—conduct disorder	0.000169	0.000347	CbGpPWpGaD
Sunitinib—TBK1—Innate Immune System—EP300—conduct disorder	0.000166	0.000342	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—HTR2A—conduct disorder	0.000166	0.000341	CbGpPWpGaD
Sunitinib—RPS6KA3—Developmental Biology—EP300—conduct disorder	0.000163	0.000336	CbGpPWpGaD
Sunitinib—CSNK1G2—Disease—EP300—conduct disorder	0.000163	0.000336	CbGpPWpGaD
Sunitinib—GRK1—Disease—EP300—conduct disorder	0.000163	0.000336	CbGpPWpGaD
Sunitinib—CSNK1E—Cell Cycle—EP300—conduct disorder	0.000163	0.000334	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—WASF1—conduct disorder	0.000162	0.000333	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—EP300—conduct disorder	0.00016	0.00033	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—DRD4—conduct disorder	0.000159	0.000326	CbGpPWpGaD
Sunitinib—JAK2—Chromatin modifying enzymes—EP300—conduct disorder	0.000158	0.000325	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CGA—conduct disorder	0.000158	0.000324	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—DRD4—conduct disorder	0.000157	0.000323	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000155	0.000318	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000154	0.000316	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—WASF1—conduct disorder	0.000153	0.000315	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—HTR2A—conduct disorder	0.000153	0.000315	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—HTR2A—conduct disorder	0.000153	0.000315	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling by Wnt—EP300—conduct disorder	0.00015	0.000308	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—DRD4—conduct disorder	0.000149	0.000307	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—WASF1—conduct disorder	0.000149	0.000306	CbGpPWpGaD
Sunitinib—IRAK4—Innate Immune System—EP300—conduct disorder	0.000148	0.000305	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CGA—conduct disorder	0.000148	0.000305	CbGpPWpGaD
Sunitinib—PHKG2—Disease—EP300—conduct disorder	0.000148	0.000303	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CGA—conduct disorder	0.000147	0.000303	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—WASF1—conduct disorder	0.000147	0.000302	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—DRD4—conduct disorder	0.000147	0.000302	CbGpPWpGaD
Sunitinib—PHKG1—Metabolism—EP300—conduct disorder	0.000145	0.000299	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—HTR2A—conduct disorder	0.000145	0.000298	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—WASF1—conduct disorder	0.000144	0.000297	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—WASF1—conduct disorder	0.000144	0.000297	CbGpPWpGaD
Sunitinib—RPS6KA3—Innate Immune System—EP300—conduct disorder	0.000144	0.000296	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—EP300—conduct disorder	0.000144	0.000296	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—DRD4—conduct disorder	0.000144	0.000296	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—HTR2A—conduct disorder	0.000143	0.000294	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CGA—conduct disorder	0.000143	0.000294	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—EP300—conduct disorder	0.000143	0.000294	CbGpPWpGaD
Sunitinib—ITK—Immune System—EP300—conduct disorder	0.000143	0.000293	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CGA—conduct disorder	0.000142	0.000291	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CGA—conduct disorder	0.000141	0.00029	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—DRD4—conduct disorder	0.00014	0.000287	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—DRD4—conduct disorder	0.000139	0.000285	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—DRD4—conduct disorder	0.000138	0.000283	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—WASF1—conduct disorder	0.000137	0.000282	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—WASF1—conduct disorder	0.000137	0.000281	CbGpPWpGaD
Sunitinib—CSNK1G2—Metabolism—EP300—conduct disorder	0.000137	0.000281	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—HTR2A—conduct disorder	0.000136	0.000281	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—EP300—conduct disorder	0.000136	0.00028	CbGpPWpGaD
Sunitinib—PAK3—Immune System—EP300—conduct disorder	0.000136	0.000279	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—EP300—conduct disorder	0.000135	0.000278	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—DRD4—conduct disorder	0.000134	0.000275	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—DRD4—conduct disorder	0.000134	0.000275	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—DRD4—conduct disorder	0.000134	0.000274	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—DRD4—conduct disorder	0.00013	0.000268	CbGpPWpGaD
Sunitinib—CSNK2A1—Disease—EP300—conduct disorder	0.000129	0.000266	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—HTR2A—conduct disorder	0.000129	0.000264	CbGpPWpGaD
Sunitinib—FGR—Innate Immune System—EP300—conduct disorder	0.000129	0.000264	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—HTR2A—conduct disorder	0.000128	0.000262	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—WASF1—conduct disorder	0.000126	0.00026	CbGpPWpGaD
Sunitinib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000126	0.000258	CbGpPWpGaD
Sunitinib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000125	0.000256	CbGpPWpGaD
Sunitinib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000124	0.000255	CbGpPWpGaD
Sunitinib—PHKG2—Metabolism—EP300—conduct disorder	0.000124	0.000254	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000123	0.000253	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—WASF1—conduct disorder	0.000119	0.000244	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—EP300—conduct disorder	0.000119	0.000244	CbGpPWpGaD
Sunitinib—STK11—Metabolism—EP300—conduct disorder	0.000119	0.000244	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—WASF1—conduct disorder	0.000118	0.000243	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—EP300—conduct disorder	0.000117	0.000242	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—EP300—conduct disorder	0.000117	0.000241	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—EP300—conduct disorder	0.000115	0.000237	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—HTR2A—conduct disorder	0.000115	0.000236	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—EP300—conduct disorder	0.000114	0.000235	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—EP300—conduct disorder	0.000114	0.000235	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—DRD4—conduct disorder	0.000113	0.000232	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—WASF1—conduct disorder	0.000113	0.000232	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—HTR2A—conduct disorder	0.00011	0.000227	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—EP300—conduct disorder	0.000108	0.000223	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—EP300—conduct disorder	0.000108	0.000222	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—DRD4—conduct disorder	0.000107	0.00022	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—EP300—conduct disorder	0.000105	0.000217	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—DRD4—conduct disorder	0.000104	0.000214	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—EP300—conduct disorder	0.000104	0.000213	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—HTR2A—conduct disorder	0.000103	0.000213	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—EP300—conduct disorder	0.000103	0.000212	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—DRD4—conduct disorder	0.000103	0.000211	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—HTR2A—conduct disorder	0.000103	0.000211	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CGA—conduct disorder	0.000102	0.00021	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—DRD4—conduct disorder	0.000101	0.000208	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—DRD4—conduct disorder	0.000101	0.000208	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—EP300—conduct disorder	9.96e-05	0.000205	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—EP300—conduct disorder	9.91e-05	0.000204	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—EP300—conduct disorder	9.84e-05	0.000202	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—HTR2A—conduct disorder	9.74e-05	0.0002	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—EP300—conduct disorder	9.7e-05	0.000199	CbGpPWpGaD
Sunitinib—TBK1—Immune System—EP300—conduct disorder	9.69e-05	0.000199	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—HTR2A—conduct disorder	9.59e-05	0.000197	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—DRD4—conduct disorder	9.58e-05	0.000197	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—DRD4—conduct disorder	9.56e-05	0.000196	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—EP300—conduct disorder	9.55e-05	0.000196	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—EP300—conduct disorder	9.54e-05	0.000196	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—EP300—conduct disorder	9.51e-05	0.000195	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—EP300—conduct disorder	9.43e-05	0.000194	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—HTR2A—conduct disorder	9.39e-05	0.000193	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—EP300—conduct disorder	9.3e-05	0.000191	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—EP300—conduct disorder	9.29e-05	0.000191	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—EP300—conduct disorder	9.27e-05	0.00019	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—EP300—conduct disorder	9.27e-05	0.00019	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—EP300—conduct disorder	9.17e-05	0.000188	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—HTR2A—conduct disorder	9.12e-05	0.000187	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—EP300—conduct disorder	9.07e-05	0.000186	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—EP300—conduct disorder	9.07e-05	0.000186	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—HTR2A—conduct disorder	9.05e-05	0.000186	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—HTR2A—conduct disorder	8.99e-05	0.000185	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—DRD4—conduct disorder	8.82e-05	0.000181	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—EP300—conduct disorder	8.79e-05	0.000181	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—EP300—conduct disorder	8.79e-05	0.000181	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—EP300—conduct disorder	8.77e-05	0.00018	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—HTR2A—conduct disorder	8.72e-05	0.000179	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—HTR2A—conduct disorder	8.72e-05	0.000179	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—HTR2A—conduct disorder	8.71e-05	0.000179	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—EP300—conduct disorder	8.63e-05	0.000178	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—EP300—conduct disorder	8.62e-05	0.000177	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	8.61e-05	0.000177	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—EP300—conduct disorder	8.58e-05	0.000176	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HTR2A—conduct disorder	8.49e-05	0.000175	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—EP300—conduct disorder	8.46e-05	0.000174	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—EP300—conduct disorder	8.4e-05	0.000173	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—EP300—conduct disorder	8.34e-05	0.000171	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—DRD4—conduct disorder	8.3e-05	0.000171	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—DRD4—conduct disorder	8.25e-05	0.00017	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—EP300—conduct disorder	8.2e-05	0.000169	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—EP300—conduct disorder	8.11e-05	0.000167	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—EP300—conduct disorder	8.1e-05	0.000166	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	8.04e-05	0.000165	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—EP300—conduct disorder	8.04e-05	0.000165	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—EP300—conduct disorder	7.9e-05	0.000162	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—DRD4—conduct disorder	7.89e-05	0.000162	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CGA—conduct disorder	7.73e-05	0.000159	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—EP300—conduct disorder	7.7e-05	0.000158	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—EP300—conduct disorder	7.67e-05	0.000158	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—EP300—conduct disorder	7.62e-05	0.000157	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—EP300—conduct disorder	7.59e-05	0.000156	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—EP300—conduct disorder	7.58e-05	0.000156	CbGpPWpGaD
Sunitinib—BLK—Immune System—EP300—conduct disorder	7.51e-05	0.000154	CbGpPWpGaD
Sunitinib—FGR—Immune System—EP300—conduct disorder	7.49e-05	0.000154	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HTR2A—conduct disorder	7.37e-05	0.000152	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—EP300—conduct disorder	7.24e-05	0.000149	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—EP300—conduct disorder	7.23e-05	0.000149	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HTR2A—conduct disorder	6.99e-05	0.000144	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—EP300—conduct disorder	6.82e-05	0.00014	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HTR2A—conduct disorder	6.79e-05	0.00014	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—EP300—conduct disorder	6.76e-05	0.000139	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HTR2A—conduct disorder	6.71e-05	0.000138	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HTR2A—conduct disorder	6.59e-05	0.000135	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HTR2A—conduct disorder	6.59e-05	0.000135	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—COMT—conduct disorder	6.45e-05	0.000133	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MAOA—conduct disorder	6.41e-05	0.000132	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—COMT—conduct disorder	6.39e-05	0.000131	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MAOA—conduct disorder	6.35e-05	0.000131	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HTR2A—conduct disorder	6.25e-05	0.000128	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HTR2A—conduct disorder	6.23e-05	0.000128	CbGpPWpGaD
Sunitinib—YES1—Immune System—EP300—conduct disorder	6.04e-05	0.000124	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—EP300—conduct disorder	5.84e-05	0.00012	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HTR2A—conduct disorder	5.76e-05	0.000118	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—EP300—conduct disorder	5.73e-05	0.000118	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	5.62e-05	0.000115	CbGpPWpGaD
Sunitinib—TYK2—Immune System—EP300—conduct disorder	5.56e-05	0.000114	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—EP300—conduct disorder	5.5e-05	0.000113	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—EP300—conduct disorder	5.48e-05	0.000113	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EP300—conduct disorder	5.43e-05	0.000112	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HTR2A—conduct disorder	5.41e-05	0.000111	CbGpPWpGaD
Sunitinib—KIT—Immune System—EP300—conduct disorder	5.4e-05	0.000111	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EP300—conduct disorder	5.4e-05	0.000111	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HTR2A—conduct disorder	5.38e-05	0.000111	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HTR2A—conduct disorder	5.15e-05	0.000106	CbGpPWpGaD
Sunitinib—TYK2—Disease—EP300—conduct disorder	5.14e-05	0.000106	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EP300—conduct disorder	5.12e-05	0.000105	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EP300—conduct disorder	5.11e-05	0.000105	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EP300—conduct disorder	5.07e-05	0.000104	CbGpPWpGaD
Sunitinib—KIT—Disease—EP300—conduct disorder	4.98e-05	0.000102	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EP300—conduct disorder	4.98e-05	0.000102	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EP300—conduct disorder	4.79e-05	9.85e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EP300—conduct disorder	4.76e-05	9.79e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CGA—conduct disorder	4.76e-05	9.79e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EP300—conduct disorder	4.73e-05	9.72e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EP300—conduct disorder	4.72e-05	9.7e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EP300—conduct disorder	4.72e-05	9.7e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—COMT—conduct disorder	4.62e-05	9.5e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EP300—conduct disorder	4.62e-05	9.49e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EP300—conduct disorder	4.62e-05	9.49e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EP300—conduct disorder	4.6e-05	9.46e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MAOA—conduct disorder	4.59e-05	9.43e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EP300—conduct disorder	4.5e-05	9.25e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—EP300—conduct disorder	4.44e-05	9.12e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EP300—conduct disorder	4.41e-05	9.07e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EP300—conduct disorder	4.35e-05	8.95e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EP300—conduct disorder	4.25e-05	8.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EP300—conduct disorder	4.22e-05	8.67e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—EP300—conduct disorder	4.1e-05	8.42e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EP300—conduct disorder	4.07e-05	8.37e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EP300—conduct disorder	3.91e-05	8.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—EP300—conduct disorder	3.89e-05	8e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EP300—conduct disorder	3.71e-05	7.62e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EP300—conduct disorder	3.6e-05	7.4e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EP300—conduct disorder	3.55e-05	7.3e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EP300—conduct disorder	3.49e-05	7.17e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EP300—conduct disorder	3.49e-05	7.17e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—COMT—conduct disorder	3.49e-05	7.17e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MAOA—conduct disorder	3.46e-05	7.12e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EP300—conduct disorder	3.31e-05	6.81e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EP300—conduct disorder	3.3e-05	6.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EP300—conduct disorder	3.05e-05	6.27e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EP300—conduct disorder	2.98e-05	6.12e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EP300—conduct disorder	2.87e-05	5.9e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EP300—conduct disorder	2.85e-05	5.86e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—EP300—conduct disorder	2.77e-05	5.69e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—EP300—conduct disorder	2.74e-05	5.64e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EP300—conduct disorder	2.73e-05	5.6e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—COMT—conduct disorder	2.15e-05	4.42e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MAOA—conduct disorder	2.13e-05	4.39e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—EP300—conduct disorder	1.98e-05	4.07e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—EP300—conduct disorder	1.5e-05	3.07e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—EP300—conduct disorder	9.22e-06	1.89e-05	CbGpPWpGaD
